Basic Information
Basic information for FTX-220-33aa
Peptide Name FTX-220-33aa
Genome Position chrX:74006236-74006334[-]
Species Human
Peptide Sequence MYPRNHCPEQHHRAFPLYFLLVVLQFQRQHFRL
Peptide Length 33
Unique No (FTX-213-33aa,FTX-214-33aa,FTX-215-33aa,FTX-217-33aa,FTX-226-33aa)
Grand Average of Hydropathicity -0.4364
Relative Molecular Mass 4799.43
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000651392;FTX-220
Transcript Length 4008
Coding Ability 0.3473
DNA Sequence Corresponding to Peptide ATGTATCCAAGAAATCATTGCCCAGAACAACATCATAGAGCTTTTCCCCTATATTTTCTACTAGTAGTTTTACAGTTTCAAAGGCAACATTTCAGGCTT
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :